Vit C can cut risk of gout; Canadian study

16 March 2009

Men with higher vitamin C intake appear less likely to develop gout, according to a report in the Archives of Internal Medicine.

Researchers at University of British Columbia, Canada,  examined the  relationship between vitamin C intake and gout in 46,994 men between  1986 and 2006. Every four years, the men completed a dietary  questionnaire, and their vitamin C intake through food and supplements  was computed.

During 20 years of follow-up, 1,317 men developed gout. Compared with  men who had a vitamin C intake of less than 250mg per day, the relative  risk of gout was 17% lower for those with a daily intake of 500mg to  999mg, 34% reduced for those who took 1,000mg to 1,499mg per day and 45%  down for those on 1,500mg per day or higher.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight